Veradigm Inc. (MDRX) Financials
MDRX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2022-12-31 | ? | ? |
2022-09-30 | 1.7 billion | 513.7 million |
2022-06-30 | 1.7 billion | 517.9 million |
2022-03-31 | 2.4 billion | 1.1 billion |
MDRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2022-12-31 | ? | ? |
2022-09-30 | 20.0 million | 4.6 million |
2022-06-30 | -11.6 million | 9.0 million |
2022-03-31 | 59.3 million | 6.3 million |
MDRX Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2022-12-31 | ? |
2022-09-30 | 14.6 million |
2022-06-30 | 3.2 million |
2022-03-31 | 18.5 million |
MDRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2022-12-31 | - | - | - |
2022-09-30 | 492.6 million | 200.3 million | 18.5 million |
2022-06-30 | 500.2 million | 199.9 million | 20.0 million |
2022-03-31 | 82.8 million | 377.1 million | 21.2 million |
MDRX Shares Outstanding
MDRX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2022-12-31 | - | - | - | - |
2022-09-30 | 8.2 million | 23.6 million | 32.5 million | - |
2022-06-30 | 9.9 million | 22.8 million | 59.9 million | - |
2022-03-31 | 10.0 million | 23.4 million | 41.3 million | - |
MDRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2022-12-31 | - | - |
2022-09-30 | 151.9 million | 68.5 million |
2022-06-30 | 150.9 million | 71.4 million |
2022-03-31 | 142.7 million | 69.2 million |
MDRX
Price: $7.70
52 week price:
Earnings Per Share: 0.86 USD
P/E Ratio: 9.66
Exchange: PNK
Sector: Healthcare
Industry: Health Information Services
Volume: 601409
Ebitda: 44.1 millionMarket Capitalization: 801.9 million